APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Coagulation Factor IX

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Coagulation Factor IX Industry Growth and Trends Forecast to 2032

22 December 2025100 pages

Choose your research edition.

Industry ResearchHuman Coagulation Factor IX Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Coagulation Factor IX Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Human Coagulation Factor IX Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Coagulation Factor IX Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Coagulation Factor IX Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Human Coagulation Factor IX market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Coagulation Factor IX is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Coagulation Factor IX is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Coagulation Factor IX is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Coagulation Factor IX include BPL, CSL, Greencross, Grifols, Kedrion, Octapharma, Baxter, Bayer and Biogen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Coagulation Factor IX market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Coagulation Factor IX market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Coagulation Factor IX market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Coagulation Factor IX.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Coagulation Factor IX market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Coagulation Factor IX Market by Company

BPL

CSL

Greencross

Grifols

Kedrion

Octapharma

Baxter

Bayer

Biogen

Hualan Bio

Pfizer

RAAS

Novo Nordisk

Human Coagulation Factor IX Segment by Type

AHGB

AHFB

Others

Human Coagulation Factor IX Segment by Application

Hospital

Personal Clinic

Others

Human Coagulation Factor IX Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor IX market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor IX and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor IX.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Coagulation Factor IX manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Coagulation Factor IX in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of AHGB Table 2. Major Company of AHFB Table 3. Major Company of Others Table 4. Global Human Coagulation Factor IX Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Human Coagulation Factor IX Sales by Type (2021-2026) & (k units) Table 6. Global Human Coagulation Factor IX Sales Market Share in Volume by Type (2021-2026) Table 7. Global Human Coagulation Factor IX Sales by Type (2021-2026) & (US$ Million) Table 8. Global Human Coagulation Factor IX Sales Market Share in Value by Type (2021-2026) Table 9. Global Human Coagulation Factor IX Price by Type (2021-2026) & (US$/unit) Table 10. Global Human Coagulation Factor IX Sales by Type (2027-2032) & (k units) Table 11. Global Human Coagulation Factor IX Sales Market Share in Volume by Type (2027-2032) Table 12. Global Human Coagulation Factor IX Sales by Type (2027-2032) & (US$ Million) Table 13. Global Human Coagulation Factor IX Sales Market Share in Value by Type (2027-2032) Table 14. Global Human Coagulation Factor IX Price by Type (2027-2032) & (US$/unit) Table 15. North America Human Coagulation Factor IX Sales by Type (2021-2026) & (k units) Table 16. North America Human Coagulation Factor IX Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Human Coagulation Factor IX Sales by Type (2021-2026) & (k units) Table 18. Europe Human Coagulation Factor IX Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Human Coagulation Factor IX Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Human Coagulation Factor IX Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Human Coagulation Factor IX Sales by Type (2021-2026) & (k units) Table 22. Latin America Human Coagulation Factor IX Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Human Coagulation Factor IX Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Human Coagulation Factor IX Sales by Type (2021-2026) & (US$ Million) Table 25. Human Coagulation Factor IX Industry Trends Table 26. Human Coagulation Factor IX Industry Drivers Table 27. Human Coagulation Factor IX Industry Opportunities and Challenges Table 28. Human Coagulation Factor IX Industry Restraints Table 29. Global Human Coagulation Factor IX Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Human Coagulation Factor IX Revenue Market Share by Company (2021-2026) Table 31. Global Human Coagulation Factor IX Sales by Company (2021-2026) & (k units) Table 32. Global Human Coagulation Factor IX Sales Share by Company (2021-2026) Table 33. Global Human Coagulation Factor IX Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Human Coagulation Factor IX Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Human Coagulation Factor IX Major Company Production Sites and Headquarters Table 36. Global Human Coagulation Factor IX Company, Product Type & Application Table 37. Global Human Coagulation Factor IX Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Human Coagulation Factor IX by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Human Coagulation Factor IX Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Human Coagulation Factor IX Sales by Region (2021-2026) & (k units) Table 42. Global Human Coagulation Factor IX Sales Market Share in Volume by Region (2021-2026) Table 43. Global Human Coagulation Factor IX Sales by Region (2021-2026) & (US$ Million) Table 44. Global Human Coagulation Factor IX Sales Market Share in Value by Region (2021-2026) Table 45. Global Human Coagulation Factor IX Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Human Coagulation Factor IX Sales by Region (2027-2032) & (k units) Table 47. Global Human Coagulation Factor IX Sales Market Share in Volume by Region (2027-2032) Table 48. Global Human Coagulation Factor IX Sales by Region (2027-2032) & (US$ Million) Table 49. Global Human Coagulation Factor IX Sales Market Share in Value by Region (2027-2032) Table 50. Global Human Coagulation Factor IX Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Human Coagulation Factor IX Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Human Coagulation Factor IX Sales by Application (2021-2026) & (k units) Table 53. Global Human Coagulation Factor IX Sales Market Share in Volume by Application (2021-2026) Table 54. Global Human Coagulation Factor IX Sales by Application (2021-2026) & (US$ Million) Table 55. Global Human Coagulation Factor IX Sales Market Share in Value by Application (2021-2026) Table 56. Global Human Coagulation Factor IX Price by Application (2021-2026) & (US$/unit) Table 57. Global Human Coagulation Factor IX Sales by Application (2027-2032) & (k units) Table 58. Global Human Coagulation Factor IX Sales Market Share in Volume by Application (2027-2032) Table 59. Global Human Coagulation Factor IX Sales by Application (2027-2032) & (US$ Million) Table 60. Global Human Coagulation Factor IX Sales Market Share in Value by Application (2027-2032) Table 61. Global Human Coagulation Factor IX Price by Application (2027-2032) & (US$/unit) Table 62. North America Human Coagulation Factor IX Sales by Application (2021-2026) & (k units) Table 63. North America Human Coagulation Factor IX Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Human Coagulation Factor IX Sales by Application (2021-2026) & (k units) Table 65. Europe Human Coagulation Factor IX Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Human Coagulation Factor IX Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Human Coagulation Factor IX Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Human Coagulation Factor IX Sales by Application (2021-2026) & (k units) Table 69. Latin America Human Coagulation Factor IX Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Human Coagulation Factor IX Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Human Coagulation Factor IX Sales by Application (2021-2026) & (US$ Million) Table 72. BPL Company Information Table 73. BPL Business Overview Table 74. BPL Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. BPL Human Coagulation Factor IX Product Portfolio Table 76. BPL Recent Development Table 77. CSL Company Information Table 78. CSL Business Overview Table 79. CSL Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. CSL Human Coagulation Factor IX Product Portfolio Table 81. CSL Recent Development Table 82. Greencross Company Information Table 83. Greencross Business Overview Table 84. Greencross Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Greencross Human Coagulation Factor IX Product Portfolio Table 86. Greencross Recent Development Table 87. Grifols Company Information Table 88. Grifols Business Overview Table 89. Grifols Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Grifols Human Coagulation Factor IX Product Portfolio Table 91. Grifols Recent Development Table 92. Kedrion Company Information Table 93. Kedrion Business Overview Table 94. Kedrion Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Kedrion Human Coagulation Factor IX Product Portfolio Table 96. Kedrion Recent Development Table 97. Octapharma Company Information Table 98. Octapharma Business Overview Table 99. Octapharma Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Octapharma Human Coagulation Factor IX Product Portfolio Table 101. Octapharma Recent Development Table 102. Baxter Company Information Table 103. Baxter Business Overview Table 104. Baxter Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Baxter Human Coagulation Factor IX Product Portfolio Table 106. Baxter Recent Development Table 107. Bayer Company Information Table 108. Bayer Business Overview Table 109. Bayer Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Bayer Human Coagulation Factor IX Product Portfolio Table 111. Bayer Recent Development Table 112. Biogen Company Information Table 113. Biogen Business Overview Table 114. Biogen Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Biogen Human Coagulation Factor IX Product Portfolio Table 116. Biogen Recent Development Table 117. Hualan Bio Company Information Table 118. Hualan Bio Business Overview Table 119. Hualan Bio Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Hualan Bio Human Coagulation Factor IX Product Portfolio Table 121. Hualan Bio Recent Development Table 122. Pfizer Company Information Table 123. Pfizer Business Overview Table 124. Pfizer Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Pfizer Human Coagulation Factor IX Product Portfolio Table 126. Pfizer Recent Development Table 127. RAAS Company Information Table 128. RAAS Business Overview Table 129. RAAS Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. RAAS Human Coagulation Factor IX Product Portfolio Table 131. RAAS Recent Development Table 132. Novo Nordisk Company Information Table 133. Novo Nordisk Business Overview Table 134. Novo Nordisk Human Coagulation Factor IX Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Novo Nordisk Human Coagulation Factor IX Product Portfolio Table 136. Novo Nordisk Recent Development Table 137. North America Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. North America Human Coagulation Factor IX Sales by Country (2021-2026) & (k units) Table 139. North America Human Coagulation Factor IX Sales Market Share by Country (2021-2026) Table 140. North America Human Coagulation Factor IX Sales Forecast by Country (2027-2032) & (k units) Table 141. North America Human Coagulation Factor IX Sales Market Share Forecast by Country (2027-2032) Table 142. North America Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Human Coagulation Factor IX Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Human Coagulation Factor IX Market Share by Country (2021-2026) Table 145. North America Human Coagulation Factor IX Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Human Coagulation Factor IX Market Share Forecast by Country (2027-2032) Table 147. Europe Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Europe Human Coagulation Factor IX Sales by Country (2021-2026) & (k units) Table 149. Europe Human Coagulation Factor IX Sales Market Share by Country (2021-2026) Table 150. Europe Human Coagulation Factor IX Sales Forecast by Country (2027-2032) & (k units) Table 151. Europe Human Coagulation Factor IX Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Human Coagulation Factor IX Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Human Coagulation Factor IX Market Share by Country (2021-2026) Table 155. Europe Human Coagulation Factor IX Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Human Coagulation Factor IX Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Human Coagulation Factor IX Sales by Country (2021-2026) & (k units) Table 159. Asia-Pacific Human Coagulation Factor IX Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Human Coagulation Factor IX Sales Forecast by Country (2027-2032) & (k units) Table 161. Asia-Pacific Human Coagulation Factor IX Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Human Coagulation Factor IX Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Human Coagulation Factor IX Market Share by Country (2021-2026) Table 165. Asia-Pacific Human Coagulation Factor IX Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Human Coagulation Factor IX Market Share Forecast by Country (2027-2032) Table 167. Latin America Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 168. Latin America Human Coagulation Factor IX Sales by Country (2021-2026) & (k units) Table 169. Latin America Human Coagulation Factor IX Sales Market Share by Country (2021-2026) Table 170. Latin America Human Coagulation Factor IX Sales Forecast by Country (2027-2032) & (k units) Table 171. Latin America Human Coagulation Factor IX Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Human Coagulation Factor IX Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Human Coagulation Factor IX Market Share by Country (2021-2026) Table 175. Latin America Human Coagulation Factor IX Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Human Coagulation Factor IX Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Human Coagulation Factor IX Sales by Country (2021-2026) & (k units) Table 179. Middle East and Africa Human Coagulation Factor IX Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Human Coagulation Factor IX Sales Forecast by Country (2027-2032) & (k units) Table 181. Middle East and Africa Human Coagulation Factor IX Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Human Coagulation Factor IX Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Human Coagulation Factor IX Market Share by Country (2021-2026) Table 185. Middle East and Africa Human Coagulation Factor IX Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Human Coagulation Factor IX Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Human Coagulation Factor IX Distributors List Table 190. Human Coagulation Factor IX Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Human Coagulation Factor IX Image Figure 2. Global Human Coagulation Factor IX Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Coagulation Factor IX Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Coagulation Factor IX Sales (2021-2032) & (k units) Figure 5. AHGB Image Figure 6. Global AHGB Sales YoY Growth (2021-2032) & (k units) Figure 7. AHFB Image Figure 8. Global AHFB Sales YoY Growth (2021-2032) & (k units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Human Coagulation Factor IX Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Human Coagulation Factor IX Market Share by Type 2025 VS 2032 Figure 13. North America Human Coagulation Factor IX Sales Market Share in Volume by Type in 2025 Figure 14. North America Human Coagulation Factor IX Sales Market Share in Value by Type in 2025 Figure 15. Europe Human Coagulation Factor IX Sales Market Share in Volume by Type in 2025 Figure 16. Europe Human Coagulation Factor IX Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Human Coagulation Factor IX Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Human Coagulation Factor IX Sales Market Share in Value by Type in 2025 Figure 19. Latin America Human Coagulation Factor IX Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Human Coagulation Factor IX Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Human Coagulation Factor IX Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Human Coagulation Factor IX Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Human Coagulation Factor IX Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 27. Personal Clinic Image Figure 28. Global Personal Clinic Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Human Coagulation Factor IX Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Human Coagulation Factor IX Market Share by Application 2025 VS 2032 Figure 33. North America Human Coagulation Factor IX Sales Market Share in Volume by Application in 2025 Figure 34. North America Human Coagulation Factor IX Sales Market Share in Value by Application in 2025 Figure 35. Europe Human Coagulation Factor IX Sales Market Share in Volume by Application in 2025 Figure 36. Europe Human Coagulation Factor IX Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Human Coagulation Factor IX Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Human Coagulation Factor IX Sales Market Share in Value by Application in 2025 Figure 39. Latin America Human Coagulation Factor IX Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Human Coagulation Factor IX Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Human Coagulation Factor IX Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Human Coagulation Factor IX Sales Market Share in Value by Application in 2025 Figure 43. North America Human Coagulation Factor IX Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Human Coagulation Factor IX Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Human Coagulation Factor IX Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Human Coagulation Factor IX Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Human Coagulation Factor IX Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Human Coagulation Factor IX Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Human Coagulation Factor IX Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Human Coagulation Factor IX Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Human Coagulation Factor IX Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Human Coagulation Factor IX Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Human Coagulation Factor IX Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Human Coagulation Factor IX Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Human Coagulation Factor IX Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Human Coagulation Factor IX Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Human Coagulation Factor IX Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Human Coagulation Factor IX Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Human Coagulation Factor IX Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Human Coagulation Factor IX Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Human Coagulation Factor IX Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Human Coagulation Factor IX Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Human Coagulation Factor IX Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Human Coagulation Factor IX Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • AHGB
  • AHFB
  • Others
Applications
  • Hospital
  • Personal Clinic
  • Others
Companies covered
  • BPL
  • CSL
  • Greencross
  • Grifols
  • Kedrion
  • Octapharma
  • Baxter
  • Bayer
  • Biogen
  • Hualan Bio
  • Pfizer
  • RAAS
  • Novo Nordisk

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Coagulation Factor IX Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Coagulation Factor IX Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Coagulation Factor IX Market by Type
  6. 1.3.1 AHGB
  7. 1.3.2 AHFB
  8. 1.3.3 Others
  9. 1.4 Global Human Coagulation Factor IX Market Size by Type
  10. 1.4.1 Global Human Coagulation Factor IX Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Human Coagulation Factor IX Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Human Coagulation Factor IX Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Human Coagulation Factor IX Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Human Coagulation Factor IX Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Human Coagulation Factor IX Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Human Coagulation Factor IX Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Human Coagulation Factor IX Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Coagulation Factor IX Industry Trends
  2. 2.2 Human Coagulation Factor IX Industry Drivers
  3. 2.3 Human Coagulation Factor IX Industry Opportunities and Challenges
  4. 2.4 Human Coagulation Factor IX Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Coagulation Factor IX Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Coagulation Factor IX Sales (2021-2026)
  3. 3.3 Global Top Players by Human Coagulation Factor IX Price (2021-2026)
  4. 3.4 Global Human Coagulation Factor IX Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Coagulation Factor IX Major Company Production Sites & Headquarters
  6. 3.6 Global Human Coagulation Factor IX Company, Product Type & Application
  7. 3.7 Global Human Coagulation Factor IX Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Coagulation Factor IX Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Coagulation Factor IX Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Coagulation Factor IX Tier 1, Tier 2, and Tier 3
4 Human Coagulation Factor IX Regional Status and Outlook
  1. 4.1 Global Human Coagulation Factor IX Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Coagulation Factor IX Historic Market Size by Region
  3. 4.2.1 Global Human Coagulation Factor IX Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Coagulation Factor IX Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Coagulation Factor IX Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Coagulation Factor IX Forecasted Market Size by Region
  7. 4.3.1 Global Human Coagulation Factor IX Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Coagulation Factor IX Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Coagulation Factor IX Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Coagulation Factor IX by Application
  1. 5.1 Human Coagulation Factor IX Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Personal Clinic
  4. 5.1.3 Others
  5. 5.2 Global Human Coagulation Factor IX Market Size by Application
  6. 5.2.1 Global Human Coagulation Factor IX Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Human Coagulation Factor IX Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Human Coagulation Factor IX Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Human Coagulation Factor IX Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Human Coagulation Factor IX Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Human Coagulation Factor IX Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Human Coagulation Factor IX Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Human Coagulation Factor IX Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BPL
  2. 6.1.1 BPL Company Information
  3. 6.1.2 BPL Business Overview
  4. 6.1.3 BPL Human Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BPL Human Coagulation Factor IX Product Portfolio
  6. 6.1.5 BPL Recent Developments
  7. 6.2 CSL
  8. 6.2.1 CSL Company Information
  9. 6.2.2 CSL Business Overview
  10. 6.2.3 CSL Human Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSL Human Coagulation Factor IX Product Portfolio
  12. 6.2.5 CSL Recent Developments
  13. 6.3 Greencross
  14. 6.3.1 Greencross Company Information
  15. 6.3.2 Greencross Business Overview
  16. 6.3.3 Greencross Human Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Greencross Human Coagulation Factor IX Product Portfolio
  18. 6.3.5 Greencross Recent Developments
  19. 6.4 Grifols
  20. 6.4.1 Grifols Company Information
  21. 6.4.2 Grifols Business Overview
  22. 6.4.3 Grifols Human Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Grifols Human Coagulation Factor IX Product Portfolio
  24. 6.4.5 Grifols Recent Developments
  25. 6.5 Kedrion
  26. 6.5.1 Kedrion Company Information
  27. 6.5.2 Kedrion Business Overview
  28. 6.5.3 Kedrion Human Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kedrion Human Coagulation Factor IX Product Portfolio
  30. 6.5.5 Kedrion Recent Developments
  31. 6.6 Octapharma
  32. 6.6.1 Octapharma Company Information
  33. 6.6.2 Octapharma Business Overview
  34. 6.6.3 Octapharma Human Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Octapharma Human Coagulation Factor IX Product Portfolio
  36. 6.6.5 Octapharma Recent Developments
  37. 6.7 Baxter
  38. 6.7.1 Baxter Company Information
  39. 6.7.2 Baxter Business Overview
  40. 6.7.3 Baxter Human Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Baxter Human Coagulation Factor IX Product Portfolio
  42. 6.7.5 Baxter Recent Developments
  43. 6.8 Bayer
  44. 6.8.1 Bayer Company Information
  45. 6.8.2 Bayer Business Overview
  46. 6.8.3 Bayer Human Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bayer Human Coagulation Factor IX Product Portfolio
  48. 6.8.5 Bayer Recent Developments
  49. 6.9 Biogen
  50. 6.9.1 Biogen Company Information
  51. 6.9.2 Biogen Business Overview
  52. 6.9.3 Biogen Human Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Biogen Human Coagulation Factor IX Product Portfolio
  54. 6.9.5 Biogen Recent Developments
  55. 6.10 Hualan Bio
  56. 6.10.1 Hualan Bio Company Information
  57. 6.10.2 Hualan Bio Business Overview
  58. 6.10.3 Hualan Bio Human Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hualan Bio Human Coagulation Factor IX Product Portfolio
  60. 6.10.5 Hualan Bio Recent Developments
  61. 6.11 Pfizer
  62. 6.11.1 Pfizer Company Information
  63. 6.11.2 Pfizer Business Overview
  64. 6.11.3 Pfizer Human Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Pfizer Human Coagulation Factor IX Product Portfolio
  66. 6.11.5 Pfizer Recent Developments
  67. 6.12 RAAS
  68. 6.12.1 RAAS Company Information
  69. 6.12.2 RAAS Business Overview
  70. 6.12.3 RAAS Human Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 RAAS Human Coagulation Factor IX Product Portfolio
  72. 6.12.5 RAAS Recent Developments
  73. 6.13 Novo Nordisk
  74. 6.13.1 Novo Nordisk Company Information
  75. 6.13.2 Novo Nordisk Business Overview
  76. 6.13.3 Novo Nordisk Human Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Novo Nordisk Human Coagulation Factor IX Product Portfolio
  78. 6.13.5 Novo Nordisk Recent Developments
7 North America by Country
  1. 7.1 North America Human Coagulation Factor IX Sales by Country
  2. 7.1.1 North America Human Coagulation Factor IX Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Coagulation Factor IX Sales by Country (2021-2026)
  4. 7.1.3 North America Human Coagulation Factor IX Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Coagulation Factor IX Market Size by Country
  6. 7.2.1 North America Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Coagulation Factor IX Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Coagulation Factor IX Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Coagulation Factor IX Sales by Country
  2. 8.1.1 Europe Human Coagulation Factor IX Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Coagulation Factor IX Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Coagulation Factor IX Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Coagulation Factor IX Market Size by Country
  6. 8.2.1 Europe Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Coagulation Factor IX Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Coagulation Factor IX Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Coagulation Factor IX Sales by Country
  2. 9.1.1 Asia-Pacific Human Coagulation Factor IX Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Coagulation Factor IX Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Coagulation Factor IX Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Coagulation Factor IX Market Size by Country
  6. 9.2.1 Asia-Pacific Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Coagulation Factor IX Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Coagulation Factor IX Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Coagulation Factor IX Sales by Country
  2. 10.1.1 South America Human Coagulation Factor IX Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Coagulation Factor IX Sales by Country (2021-2026)
  4. 10.1.3 South America Human Coagulation Factor IX Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Coagulation Factor IX Market Size by Country
  6. 10.2.1 South America Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Coagulation Factor IX Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Coagulation Factor IX Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Coagulation Factor IX Sales by Country
  2. 11.1.1 Middle East and Africa Human Coagulation Factor IX Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Coagulation Factor IX Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Coagulation Factor IX Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Coagulation Factor IX Market Size by Country
  6. 11.2.1 Middle East and Africa Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Coagulation Factor IX Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Coagulation Factor IX Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Coagulation Factor IX Value Chain Analysis
  2. 12.1.1 Human Coagulation Factor IX Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Coagulation Factor IX Production Mode & Process
  7. 12.2 Human Coagulation Factor IX Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Coagulation Factor IX Distributors
  10. 12.2.3 Human Coagulation Factor IX Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst